Lv6
1979 积分 2021-12-14 加入
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)
6天前
已完结
Management of HER2 alterations in non-small cell lung cancer – The past, present, and future
7天前
已完结
Association of Immune-Related Adverse Events with Efficacy in Patients With Small Cell Lung Cancer: a Second Analysis of Phase 3 IMpower133 Randomized Clinical Trials
1个月前
已完结
Enhanced HER2 internalization by clathrin-dependent endocytosis in non-small cell lung cancer positive for HER2 mutations
1个月前
已关闭
Promising results with zongertinib in advanced-stage HER2-mutant NSCLC
1个月前
已完结
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer
1个月前
已完结
Management of HER2 alterations in non-small cell lung cancer – The past, present, and future
1个月前
已完结
Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
2个月前
已完结
Flexible Sigmoidoscopy in the PLCO Cancer Screening Trial: Results From the Baseline Screening Examination of a Randomized Trial
2个月前
已完结
[Expert consensus on diagnosis and treatment of advanced non-small cell lung cancer with HER-2 alterations (2025 edition)]
2个月前
已完结
皖公网安备34019202002308
